SARCULATOR vs. ASCO Guidelines Utilizzo e statistiche
This app is meant to be used only by physicians and it is not meant to make clinical decisions (the clinical usefulness of the two models has not been tested) but to be used as an informative tool to improve the predictive capability of a physician.
Two kinds of predictions are possible:
- RPS: 5-year overall survival (OS) and 5-year disease-free survival (DFS) in primary resected retroperitoneal sarcoma (RPS) patients. .
- STS: 5- and 10-year overall survival (OS) and cumulative incidence of distant metastasis (CCI of DM) in primary resected extremity STS patients.
- App Store di Apple
- Gratis
- Settore Medico
Classifica degli store
- -
The ASCO Guidelines app is your go-to tool for implementing guideline recommendations into practice. This user-friendly app provides health care providers, patients, and caregivers with the recommended cancer care options for a variety of cancer types. It also includes interactive tools to inform treatment decisions at the point of care, thus increasing the quality of care provided to patients. The ASCO app is free to members and nonmembers, kept up to date, and will continue to grow as more guidelines and tools are added.
- App Store di Apple
- Gratis
- Settore Medico
Classifica degli store
- -
SARCULATORRanking a confronto con ASCO Guidelines
Confronta la tendenza di classifica SARCULATOR nei ultimi 28 giorni rispetto a ASCO Guidelines
Rank
Classifica SARCULATOR vs. ASCO Guidelines per paese a confronto
Confronta la tendenza di classifica SARCULATOR nei ultimi 28 giorni rispetto a ASCO Guidelines
Tutte le categorie
Settore Medico
Fai confronti con qualsiasi sito con la nostra prova gratuita
SARCULATOR VS. 
ASCO Guidelinesgennaio 8, 2025